News
6h
Zacks Investment Research on MSNMRK's Buyout Spree to Broaden Product Portfolio: Can it Aid Growth?Merck MRK recently intensified its acquisition strategy, actively pursuing deals to enhance its development pipeline and broaden its product portfolio. To build its long-term portfolio, the company ...
7h
DPA International on MSNChikungunya: The virus you might not know you need to worry aboutMost European travellers heading to sub-tropical regions know to make sure they're up to date on their vaccinations. While ...
The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...
Clozapine blood monitoring can now be reduced to every 12 weeks after 1 year of treatment, and annually after 2 years, in patients without neutropenia.
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa ...
HONG KONG] The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way ...
Britain said it would strike an agreement with Vietnam to make it easier for pharmaceutical firms to sell UK-made medicines ...
Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label extensions of PATHFNDR-1 and PATHFNDR-2 studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results